NASDAQ: ALEC - Alector, Inc.

Rentabilidade por seis meses: -75.29%
Rendimento de dividendos: 0.00%
Setor: Healthcare

Cronograma de promoção Alector, Inc.

Agenda avançada Gráfico simples
Financial Markets by TradingView

Sobre a empresa Alector, Inc.

Alector, Inc., биофармацевтическая компания клинической стадии, разрабатывает методы лечения нейродегенеративных заболеваний. Его продукты включают AL001, гуманизированное рекомбинантное моноклональное антитело, которое проходит фазу II клинических испытаний для лечения лобно-височной деменции; и AL101, который проходит фазу I клинических испытаний для лечения нейродегенеративных заболеваний, включая болезни Альцгеймера и Паркинсона. Компания также предлагает AL002 и AL003, которые находятся на фазе 1b клинических испытаний для лечения болезни Альцгеймера.

mais detalhes
Кроме того, у него есть 10 программ на стадии исследований и разработок. Компания заключила соглашение о сотрудничестве с Adimab, LLC в области исследования и разработки антител. Компания Alector, Inc. была основана в 2013 году, ее штаб-квартира находится в Южном Сан-Франциско, Калифорния.
Adicionar à lista de comparação
Adicionar à lista de observação
Adicionar ao portfólio
Adicionar aviso de preço

IPO date 2019-02-07
ISIN US0144421072
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Сайт http://www.alector.com
Цена ао 1.49
Alteração de preço por dia: -1.32% (1.51)
Alteração de preço por semana: -5.7% (1.58)
Alteração de preço por mês: -7.45% (1.61)
Alteração de preço em 3 meses: -26.96% (2.04)
Mudança de preço em seis meses: -75.29% (6.03)
Mudança de preço por ano: -75.37% (6.05)
Mudança de preço em 3 anos: -90.2% (15.21)
Mudança de preço em 5 anos: -93.45% (22.76)
Mudança de preço em 10 anos: 0% (1.49)
Mudança de preço desde o início do ano: -16.29% (1.78)
Todos os parâmetros

Subestimação

Nome Significado Nota
P/S 6.9 1
P/BV 4.99 3
P/E 18.21 7
EV/EBITDA -4.44 0
Total: 5.13

Eficiência

Nome Significado Nota
ROA, % -20.97 0
ROE, % -97.19 0
Total: 0

Dividendos

Nome Significado Nota
Div yield, % 0 0
DSI 0 0
Total: 0

Obrigação

Nome Significado Nota
Debt/EBITDA -0.2724 10
Total: 10

Impulso de crescimento

Nome Significado Nota
Rentabilidade Revenue, % 357.84 10
Rentabilidade Ebitda, % 24.91 4
Rentabilidade EPS, % 5.93 1
Total: 5.8
Mais detalhes

Instituições Volume Compartilhar, %
FMR, LLC 12620404 13.18
Blackrock Inc. 8068553 8.43
Morgan Stanley 4650191 4.86
Vanguard Group Inc 4386541 4.58
EcoR1 Capital, LLC 4056548 4.24
Braidwell LP 3324308 3.47
State Street Corporation 3117529 3.26
Deutsche Bank Aktiengesellschaft 2062099 2.15
JP Morgan Chase & Company 1863998 1.95
Geode Capital Management, LLC 1381786 1.44

ETFCompartilhar, %Rentabilidade para o ano, %Dividendos, %
Virtus LifeSci Biotech Clinical Trials ETF 0.92379 63.04 0.33
iShares Neuroscience and Healthcare ETF 0.81486 19.72 0.03
Global X Aging Population ETF 0.26261 20.37 1.46713
ProShares UltraShort Nasdaq Biotechnology 0.18 -40.36 1.76
iShares Micro-Cap ETF 0.11775 17.09 1.54048
Invesco Nasdaq Biotechnology ETF 0.05703 28.58 0.8565
Future Tech ETF 0.05663 426.34 0.8416
Principal Healthcare Innovators ETF 0.05663 618.5 0.8416
iShares ESG Aware MSCI USA Small-Cap ETF 0.05287 18.09 1.49366
Direxion Daily S&P Biotech Bull 3x Shares 0.04782 4067.92 0.25924
ProShares Ultra Nasdaq Biotechnology 0.03612 51.7 0.85651
iShares Russell 2000 Growth ETF 0.03434 38.04 0.6026
Vanguard Russell 2000 Growth ETF 0.03 23.05 0.60264
Nuveen ESG Small-Cap ETF 0.02612 13.91 1.41019
Vanguard Russell 2000 ETF 0.02 17.16 1.48801
Avantis U.S Small Cap Equity ETF 0.01786 27.77 1.68271
Schwab U.S. Small-Cap ETF 0.01072 17.47 1.51433
iShares Morningstar Small Cap Value ETF 0.01066 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.01066 201.65 2.50476
ProShares UltraPro Russell2000 0.01003 89.82 1.47873
iShares Morningstar Small-Cap ETF 0.00937 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00937 391.25 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00748 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00748 587.89 0.72598
Fidelity MSCI Health Care Index ETF 0.00603 3 1.46057
SPDR Portfolio MSCI Global Stock Market ETF 0.00425 17.99 2.19607
Humankind US Stock ETF 0.00375 18.81 1.99919
ProShares Hedge Replication ETF 0.00277 5.92 1.47892
Avantis U.S. Equity ETF 0.00141 23.04 1.59151
Dimensional US Core Equity Market ETF 0.00073 30.98 1.40618
iShares Russell 3000 ETF 0.00063 24.83 1.43482
Dimensional U.S. Equity ETF 0.0005 31.53 1.3557
Schwab U.S. Broad Market ETF 0.00048 24.86 1.43354
Dimensional U.S. Core Equity 2 ETF 0.00033 30.76 1.47098
Vanguard Russell 3000 ETF 0 31.87 1.43817
0.08200.941.31



Supervisor Cargo Pagamento Ano de nascimento
Dr. Marc Grasso M.D. CFO, Principal Financial Officer & Principal Accounting Officer 738.05k 1974 (51 ano)
Ms. Clare Hunt M.B.A. Chief People Officer N/A
Dr. Arnon Rosenthal Ph.D. Co-Founder, CEO & Director 1.02M 1956 (69 anos)
Ms. Danielle Pasqualone J.D., Ph.D. General Counsel N/A
Mr. Peter Heutink Ph.D. Chief Scientific Officer N/A
Ms. Kristina Cutter M.P.H. Chief Regulatory, Pharmacovigilance, & Quality Assurance Officer N/A
Dr. Gary Romano M.D., Ph.D. Chief Medical Officer 602.98k 1962 (63 ano)
Ms. Virginia DeJesus-Rueff M.B.A. Chief of Staff & Head of Strategy N/A
Dr. Saraswati Kenkare-Mitra Ph.D. President and Head of Research & Development 1968 (57 anos)
Ms. Katie Hogan Senior Director of Corporate Communication & Investor Relations

Endereço: United States, South San Francisco, CA , 131 Oyster Point Boulevard - abrir no Google Maps, abrir mapas Yandex
Site: http://www.alector.com